| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8975 |
| Human Intestinal Absorption | HIA+ | 0.8739 |
| Caco-2 Permeability | Caco2- | 0.6623 |
| P-glycoprotein Substrate | Non-substrate | 0.8062 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9832 |
| Non-inhibitor | 0.9805 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9579 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7766 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8262 |
| CYP450 2D6 Substrate | Non-substrate | 0.9299 |
| CYP450 3A4 Substrate | Non-substrate | 0.7966 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9520 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9345 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9532 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9662 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9516 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9886 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9835 |
| Non-inhibitor | 0.9878 |
| AMES Toxicity | Non AMES toxic | 0.8908 |
| Carcinogens | Non-carcinogens | 0.5186 |
| Fish Toxicity | High FHMT | 0.8401 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.9763 |
| Honey Bee Toxicity | High HBT | 0.7235 |
| Biodegradation | Ready biodegradable | 0.7545 |
| Acute Oral Toxicity | III | 0.7544 |
| Carcinogenicity (Three-class) | Non-required | 0.7116 |